Published in Hepatitis Weekly, May 22nd, 2006
The five-year study is funded by a grant from the Canadian Institutes of Health Research. The funding announcement follows a recent grant from the U.S. Department of Health to monitor the rise of drug-resistant HIV among users of crystal methamphetamine in Vancouver's Downtown Eastside.
In B.C., all anti-HIV medications are distributed at no cost to eligible HIV-infected individuals through the Center's Drug Treatment Program. In 2003, the Centre...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.